Pregabalin capsules

DRUG4 trials

Sponsors

Daiichi Sankyo Co., Ltd., Purdue Pharma LP, AstraZeneca, Shandong Suncadia Medicine Co., Ltd.

Conditions

Diabetic Neuropathy, Painful; Diabetic NeuropathiesDiabetic Peripheral Neuropathic PainDiabetic Peripheral NeuropathyPainPostherpetic Neuralgia

Phase 1

A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain

RecruitingNCT07377721

Shandong Suncadia Medicine Co., Ltd.Diabetic Peripheral Neuropathic Pain

Start: 2026-03-24End: 2026-11-01Target: 168Updated: 2026-04-15

Phase 2

Asian Phase 2 Study for Treatment of Pain Associated With Diabetic Peripheral Neuropathy

CompletedNCT01504412

Daiichi Sankyo Co., Ltd.Diabetic Peripheral Neuropathy, Pain

Start: 2012-01-31End: 2013-06-30Updated: 2020-03-18

Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)

CompletedNCT01688947

Purdue Pharma LPPain, Postherpetic Neuralgia

Start: 2012-09-30End: 2014-04-30Updated: 2014-05-12

Safety, Tolerability and Preliminary Efficacy of AZD5213 in Combination With Pregabalin in Subjects With PDN and Good Pain Reporting Ability

CompletedNCT01928381

AstraZenecaDiabetic Neuropathy, Painful; Diabetic Neuropathies

Start: 2013-11-30End: 2015-05-31Updated: 2016-10-03

Related Papers

Results of Mirogabalin Treatment for Diabetic Peripheral Neuropathic Pain in Asian Subjects: A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Study.

2020-02-1219 citations